申请人:Engelhardt Harald
公开号:US20110269958A1
公开(公告)日:2011-11-03
The present invention encompasses compounds of general formula (1) while the groups R
4
to R
7
and the units W, L, Q
a
and Q
H
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.
本发明涵盖了一般式(1)的化合物,其中R4到R7和单位W、L、Qa和QH的定义如权利要求1所述,适用于治疗由过度或异常细胞增殖特征的疾病,并且它们作为具有上述特性的药物的用途。